Kaveri Pohlman
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
22
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Downgrades: Neutral | n/a | $3.87 | - | 4 | Aug 1, 2024 | |
| GMAB Genmab | Maintains: Buy | $46 → $47 | $22.56 | +108.33% | 3 | Jun 27, 2024 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $20 → $30 | $15.78 | +90.11% | 2 | Apr 17, 2024 | |
| XNCR Xencor | Maintains: Buy | $56 → $38 | $21.26 | +78.74% | 1 | Apr 16, 2024 | |
| NUVB Nuvation Bio | Upgrades: Buy | $5 | $2.30 | +117.39% | 2 | Mar 26, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $62 | $54.39 | +13.99% | 1 | Mar 21, 2024 | |
| PYXS Pyxis Oncology | Initiates: Buy | $8 | $3.76 | +112.77% | 1 | Feb 9, 2024 | |
| EXEL Exelixis | Initiates: Buy | $27 | $34.12 | -20.87% | 1 | Dec 19, 2023 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $70 | $15.50 | +351.61% | 1 | Aug 23, 2023 | |
| STTK Shattuck Labs | Initiates: Buy | $12 | $1.25 | +860.00% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $1.05 | +661.90% | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $1.50 | +6,566.67% | 1 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12,320 → $4,928 | $4.32 | +113,974.07% | 2 | Feb 9, 2022 |
MacroGenics
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.87
Upside: -
Genmab
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $22.56
Upside: +108.33%
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $15.78
Upside: +90.11%
Xencor
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $21.26
Upside: +78.74%
Nuvation Bio
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $2.30
Upside: +117.39%
Janux Therapeutics
Mar 21, 2024
Initiates: Buy
Price Target: $62
Current: $54.39
Upside: +13.99%
Pyxis Oncology
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $3.76
Upside: +112.77%
Exelixis
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $34.12
Upside: -20.87%
Arcus Biosciences
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $15.50
Upside: +351.61%
Shattuck Labs
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $1.25
Upside: +860.00%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $1.05
Upside: +661.90%
Feb 24, 2022
Initiates: Buy
Price Target: $100
Current: $1.50
Upside: +6,566.67%
Feb 9, 2022
Maintains: Buy
Price Target: $12,320 → $4,928
Current: $4.32
Upside: +113,974.07%